Literature DB >> 20515

Stimulation of cellular thymidine kinases by human cytomegalovirus.

J E Estes, E S Huang.   

Abstract

Thymidine kinase (TK) activity in WI-38 and MRC-5 human fibroblasts was analyzed by discontinuous polyacrylamide gel electrophoresis (disc-PAGE) and discontinuous glycerol gradient electrophoresis (disc-GEP) after subculture or human cytomegalovirus (HCMV) infection. Two peaks of TK activity with different relative fraction-of-migration (R(f)) values were resolved by disc-PAGE or disc-GEP in extracts from log-phase and infected cells. Growing WI-38 cells expressed a slowly migrating (R(f) = 0.14 PAGE, R(f) = 0.4 GEP) peak of TK activity, which was partially inhibited by 1.0 mM dCTP, but which retained little activity at pH 4.5. Growing MRC cells also displayed a slowly migrating peak (R(f) = 0.10 PAGE) with similar properties. Both cell types expressed a faster-migrating TK activity (R(f) = 0.45 PAGE, R(f) = 0.7 GEP) in the growing and resting state that was strongly inhibited by 1 mM dCTP but retained 50% activity at pH 4.5. When either cell type was infected with HCMV, there was a rapid and high-level stimulation of the slowly migrating form of TK and a slight stimulation of the faster-migrating form. Two strains of HCMV (AD169 and Town) failed to produce an electrophoretically distinct virus TK in either cell type after infection. TK enzymes were partially purified by disc-GEP from extracts of log-phase WI-38 or AD169-infected WI-38 cells. Characterization of these enzymes with respect to phosphate donor specificity, pH optima, thermostability, and salt inhibition showed the HCMV-stimulated TKs to be of cellular origin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20515      PMCID: PMC515905          DOI: 10.1128/JVI.24.1.13-21.1977

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  ACRYLAMIDE GEL ELECTROPHORESIS.

Authors:  S RAYMOND
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Enzymatic synthesis of deoxyribonucleic acid. II. General properties of the reaction.

Authors:  M J BESSMAN; I R LEHMAN; E S SIMMS; A KORNBERG
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

3.  Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids.

Authors:  W P ROWE; J W HARTLEY; S WATERMAN; H C TURNER; R J HUEBNER
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

4.  Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.

Authors:  L S Lee; Y C Cheng
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

5.  Human cytomegalovirus stimulates host cell RNA synthesis.

Authors:  S Tanaka; T Furukawa; S A Plotkin
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

6.  Human cytomegalovirus. III. Virus-induced DNA polymerase.

Authors:  E S Huang
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Deoxyribonucleoside triphosphate pools in synchronized human cells infected with herpes simplex virus types 1 and 2.

Authors:  B Roller; G H Cohen
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

9.  Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis.

Authors:  J M DeMarchi; A S Kaplan
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

10.  Thymidine-kinase in cytomegalovirus infected cells.

Authors:  V Závada; V Erban; D Rezácová; V Vonka
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

View more
  60 in total

1.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.

Authors:  D Lembo; G Gribaudo; A Hofer; L Riera; M Cornaglia; A Mondo; A Angeretti; M Gariglio; L Thelander; S Landolfo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity.

Authors:  Zhigang Zhang; Shu-Mei Huong; Xin Wang; David Y Huang; Eng-Shang Huang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Production of plasminogen activator by human and hamster cells infected with human cytomegalovirus.

Authors:  K Yamanishi; F Rapp
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

5.  Specific chromosome 1 breaks induced by human cytomegalovirus.

Authors:  E A Fortunato; M L Dell'Aquila; D H Spector
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 6.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

7.  Purification and characterization of varicella-zoster virus-induced DNA polymerase.

Authors:  E C Mar; Y S Huang; E S Huang
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

Review 8.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 9.  Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.

Authors:  T Kulikowski
Journal:  Pharm World Sci       Date:  1994-04-15

10.  Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Authors:  M J Tocci; T J Livelli; H C Perry; C S Crumpacker; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.